An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.